Order Article Reprints

Bobu AM, Turliuc S, Cucu AI, Onofriescu A, Dascalu CG, Costea CF, Patrascanu E, Morosan AP, Haisan A, Filip CN, et al. Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes. Journal of Clinical Medicine. 2025; 14(10):3536. https://doi.org/10.3390/jcm14103536

Bobu, Amelian Madalin, Serban Turliuc, Andrei Ionut Cucu, Alina Onofriescu, Cristina Gena Dascalu, Claudia Florida Costea, Emilia Patrascanu, Anca Petruta Morosan, Anca Haisan, Carmen Nicoleta Filip, and et al. 2025. "Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes" Journal of Clinical Medicine 14, no. 10: 3536. https://doi.org/10.3390/jcm14103536

Bobu, A. M., Turliuc, S., Cucu, A. I., Onofriescu, A., Dascalu, C. G., Costea, C. F., Patrascanu, E., Morosan, A. P., Haisan, A., Filip, C. N., Covali, R., Buzduga, C. M., Botnariu, G., & Enache, I. I. C. (2025). Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes. Journal of Clinical Medicine, 14(10), 3536. https://doi.org/10.3390/jcm14103536